INCOME STATEMENT (Quarterly GAAP In millions $) |
(Jun 30 2024) II. Quarter |
(Mar 31 2024) I. Quarter |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
Total Revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Cost of Revenues |
- |
- |
- |
- |
- |
Gross
Profit |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Selling, Administration, Marketing |
0.22 |
0.15 |
0.33 |
0.32 |
0.22 |
Depriciation & Amortization |
0.49 |
0.48 |
0.49 |
0.47 |
0.44 |
Research and Development Expense |
0.16 |
0.17 |
0.16 |
0.23 |
0.18 |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
0.78 |
1.26 |
1.03 |
0.82 |
0.94 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
1.65 |
2.05 |
2.02 |
1.83 |
1.78 |
Operating income/-loss
|
-1.65 |
-2.05 |
-2.02 |
-1.83 |
-1.78 |
Other Deductions / - Income |
Interest expense |
- |
0.15 |
0.20 |
0.29 |
0.54 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
0.15 |
0.20 |
0.29 |
0.54 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Interest Expense Nonoperating |
0.02 |
- |
- |
- |
- |
Fair Value Adjustment Of Warrants |
0.63 |
- |
- |
- |
- |
Total costs & expenses |
2.30 |
2.21 |
2.21 |
2.12 |
2.32 |
Income /-loss before income taxes |
-2.30 |
-2.21 |
-2.21 |
-2.12 |
-2.32 |
Income taxes expenses/-benefit |
- |
- |
- |
- |
- |
Income after income taxes |
-2.30 |
-2.21 |
-2.21 |
-2.12 |
-2.32 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-2.30 |
-2.21 |
-2.21 |
-2.12 |
-2.32 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-2.30 |
-2.21 |
-2.21 |
-2.12 |
-2.32 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-2.30 |
-2.21 |
-2.21 |
-2.12 |
-2.32 |
EBIT |
-2.30 |
-2.05 |
-2.02 |
-1.83 |
-1.78 |
EBITD |
-1.81 |
-1.57 |
-1.53 |
-1.36 |
-1.34 |
EBITDA |
-1.81 |
-1.57 |
-1.53 |
-1.36 |
-1.34 |